Quick Answer
Oncology Institute, Inc. reported Net Income Loss of -$60.61 million for the year ending 2025.
- Oncology Institute, Inc. showed an increase of +6.3% in Net Income Loss from 2024 to 2025.
- This data is from Oncology Institute, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Oncology Institute, Inc.'s Net Income Loss has declined by 323.2%.
- Historical annual values: Fiscal year 2025: -$60.61 million | Fiscal year 2024: -$64.66 million | Fiscal year 2023: -$83.07 million | Fiscal year 2022: $152.0 thousand | Fiscal year 2021: -$10.93 million | Fiscal year 2020: -$14.32 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: